AHR activation inhibits MTDH phosphorylation at Ser298, which in turn suppresses nuclear factor kappa B (NF-κB) signaling pathway activity, ultimately attenuating gastric cancer progression. This evidence concerns the gene NFKB1 and gastric cancer.